"Designing Growth Strategies is in our DNA"

U.S. Dermatophytic Onychomycosis Treatment Market Size, Share & COVID-19 Impact Analysis, By Product Type (Tablets, and Nail Paints), By Route of Administration (Oral, and Topical), By Type (Prescription, and Over-the-Counter (OTC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channels), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI108477

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Dermatophytic Onchomycosis, 2022
    2. Pipeline Analysis, Key Players
    3. New Product Launches, Key Players
    4. Key Industry Developments - Mergers, Acquisitions and Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Tablets
      2. Nail Paints
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
    3. Market Analysis, Insights and Forecast – By Type
      1. Prescription
      2. Over-the-Counter (OTC)
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Channels
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Bausch Health Companies Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Galderma
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Lupin Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Zydus Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Dermatophytic Onchomycosis, 2022
    2. Pipeline Analysis, Key Players
    3. New Product Launches, Key Players
    4. Key Industry Developments - Mergers, Acquisitions and Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Tablets
      2. Nail Paints
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
    3. Market Analysis, Insights and Forecast – By Type
      1. Prescription
      2. Over-the-Counter (OTC)
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Channels
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Bausch Health Companies Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Galderma
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Lupin Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Zydus Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Other Prominent Players
Read Less

Figure 1:  U.S. Dermatophytic Onychomycosis Treatment Market Revenue Breakdown (USD Billion, %), By Product Type, 2022 & 2030

Figure 2:  U.S. Dermatophytic Onychomycosis Treatment Market Value Share (%), by Product Type, 2022 & 2030

Figure 3:  U.S. Dermatophytic Onychomycosis Treatment Market Value Share (%), by Product Type, 2022 & 2030

Figure 4:  U.S. Dermatophytic Onychomycosis Treatment Market Value Share (%), by Route of Administration, 2022 & 2030

Figure 5:  U.S. Dermatophytic Onychomycosis Treatment Market Value Share (%), by Type, 2022 & 2030

Figure 6:  U.S. Dermatophytic Onychomycosis Treatment Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 7:  U.S. Dermatophytic Onychomycosis Treatment Market Share (%), By Company, 2022

Table 1:  U.S. Dermatophytic Onychomycosis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019–2030

Table 2:  U.S. Dermatophytic Onychomycosis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2030

Table 3:  U.S. Dermatophytic Onychomycosis Treatment Market Revenue (USD billion) Forecast, by Type, 2019–2030

Table 4:  U.S. Dermatophytic Onychomycosis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030

U.S. Dermatophytic Onychomycosis Treatment Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 100
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports